ARTICLE | Clinical News
Claudetect 18 regulatory update
September 16, 2013 7:00 AM UTC
Ganymed said it received CE Mark approval for its Claudetect 18.2 in vitro diagnostic assay to assess the expression levels of CLDN18.2 in solid tumors. The semi-quantitative immunohistochemical assay...